Use of Reo Pro (Abciximab) as adjuvant therapy in percutaneous coronary angioplasty and stenting. A word of caution

John M Alvarez

Research output: Contribution to journalLetterOther

Original languageEnglish
Pages (from-to)219 - 220
Number of pages2
JournalAsia Pacific Heart Journal
Publication statusPublished - 1997

Cite this